Back to Search

THOMAS CHAUNCEY, MD

MD

Hematology & Oncology Physician

NPI: 1710077243Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

MD00024052(WA)

Research & Publications (20)

Autologous bone marrow transplantation improves disease free survival but not overall survival in people with acute myeloid leukaemia.
PMID 15245781·Cancer Treat Rev·2004
1-meta
Drug resistance mechanisms in acute leukemia.
PMID 11148681·Curr Opin Oncol·2001
6-review
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
PMID 10955873·Am J Clin Oncol·2000
4-observational
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.
PMID 10867130·Leuk Res·2000
3-trial
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
PMID 19015394·Blood·2009
3-trial
What is the role for donor natural killer cells after nonmyeloablative conditioning?
PMID 19361750·Biol Blood Marrow Transplant·2009
8-other
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.
PMID 19377515·Bone Marrow Transplant·2009
3-trial
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 18794548·J Clin Oncol·2008
8-other
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
PMID 18056679·J Clin Oncol·2008
4-observational
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
PMID 18215785·Biol Blood Marrow Transplant·2008
3-trial
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
PMID 18311781·Cancer·2008
8-other
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
PMID 18541200·Biol Blood Marrow Transplant·2008
8-other
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
PMID 18759762·Br J Haematol·2008
4-observational
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 17595333·Blood·2007
8-other
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
PMID 17287157·Biol Blood Marrow Transplant·2007
3-trial
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
PMID 17697966·Biol Blood Marrow Transplant·2007
3-trial
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
PMID 16344316·J Clin Oncol·2006
8-other
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
PMID 16545729·Biol Blood Marrow Transplant·2006
3-trial
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
PMID 16570002·Transplantation·2006
8-other
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
PMID 16896000·J Clin Oncol·2006
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1660 S COLUMBIAN WAY, MARROW TRANSPLANT UNIT (111)
SEATTLE, WA 98108

Location

Practice Location

1660 S COLUMBIAN WAY, SEATTLE, WA
(206) 764-2969

Quick Facts

NPI
1710077243
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile